Related references
Note: Only part of the references are listed.Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome
Makhloufi Zoulikha et al.
ACTA PHARMACEUTICA SINICA B (2022)
Neurotoxicity of poly(propylene imine) glycodendrimers
Ida Franiak-Pietryga et al.
DRUG AND CHEMICAL TOXICOLOGY (2022)
Advances in lipid carriers for drug delivery to the gastrointestinal tract
Yining Xu et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2021)
Amine-terminated dendritic polymers as promising nanoplatform for diagnostic and therapeutic agents' modification: A review
Mahsa Delyanee et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Stimuli-Responsive Iron Oxide Nanotheranostics: A Versatile and Powerful Approach for Cancer Therapy
Morgan E. Lorkowski et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Recent advances in nanoscale materials for antibody-based cancer theranostics
Deepak Kukkar et al.
BIOSENSORS & BIOELECTRONICS (2021)
Venetoclax as a therapeutic option for the treatment of chronic lymphocytic leukemia: the evidence so far
Lauren Held et al.
EXPERT OPINION ON PHARMACOTHERAPY (2021)
Ferritin-based targeted delivery of arsenic to diverse leukaemia types confers strong anti-leukaemia therapeutic effects
Changlong Wang et al.
NATURE NANOTECHNOLOGY (2021)
Hybrid Nanoparticles Modified by Hyaluronic Acid Loading an HSP90 Inhibitor as a Novel Delivery System for Subcutaneous and Orthotopic Colon Cancer Therapy
Chenwei Pan et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
The nanomedicine rush: New strategies for unmet medical needs based on innovative nano DDS
Yusuke Sato et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Applications of Dendrimers in Nanomedicine and Drug Delivery: A Review
Mohammad Nikzamir et al.
JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS (2021)
Myeloid Cell Leukemia-1 Inhibitors as Emerging Cancer Treatment
Ahmed F. Abdel-Magid
ACS Medicinal Chemistry Letters (2021)
Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver
M. Kim et al.
SCIENCE ADVANCES (2021)
Inorganic Nanoparticles Applied for Active Targeted Photodynamic Therapy of Breast Cancer
Hanieh Montaseri et al.
PHARMACEUTICS (2021)
Polycaprolactone Nanoparticles as Promising Candidates for Nanocarriers in Novel Nanomedicines
Sylwia Lukasiewicz et al.
PHARMACEUTICS (2021)
Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles
Michele Schlich et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)
Gold Cluster Capped with a BCL-2 Antagonistic Peptide Exerts Synergistic Antitumor Activity in Chronic Lymphocytic Leukemia Cells
Yawen Yao et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses
Muhammad Imran Sajid et al.
MOLECULAR PHARMACEUTICS (2021)
Preparation methods and applications of chitosan nanoparticles; with an outlook toward reinforcement of biodegradable packaging
Murat Yanat et al.
REACTIVE & FUNCTIONAL POLYMERS (2021)
Lipid-Based Nanoparticles in the Clinic and Clinical Trials: From Cancer Nanomedicine to COVID-19 Vaccines
Thai Thanh Hoang Thi et al.
VACCINES (2021)
PAMAM dendrimer as a talented multifunctional biomimetic nanocarrier for cancer diagnosis and therapy
Bhavya Surekha et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Auranofin reveals therapeutic anticancer potential by triggering distinct molecular cell death mechanisms and innate immunity in mutant p53 non-small cell lung cancer
Laurie Freire Boullosa et al.
REDOX BIOLOGY (2021)
Iron Oxide Nanoparticles in Bioimaging - An Immune Perspective
Mark Geppert et al.
FRONTIERS IN IMMUNOLOGY (2021)
Liposome-ligand conjugates: a review on the current state of art
Ipek Eroglu et al.
JOURNAL OF DRUG TARGETING (2020)
Mesoporous Silica Nanoparticles for Drug Delivery
Miguel Manzano et al.
ADVANCED FUNCTIONAL MATERIALS (2020)
Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Ibrutinib Delivery: A Potential Nanoformulation of Novel Kinase Inhibitor
Ludan Zhao et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic Review
Arafat Ali Farooqui et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution
Takashi Nakamura et al.
MOLECULAR PHARMACEUTICS (2020)
Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering
Margaret M. Billingsley et al.
NANO LETTERS (2020)
Biodegradable calcium phosphate nanoparticles for cancer therapy
Razieh Khalifehzadeh et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2020)
Nanocarriers as Magic Bullets in the Treatment of Leukemia
Mohammad Houshmand et al.
NANOMATERIALS (2020)
Gold Clusters Attenuate Inflammation in Rat Mesangial Cells via Inhibiting the Activation of NF-κB Pathway
Jinling Yuan et al.
NANOMATERIALS (2020)
Precision Medicine Management of Chronic Lymphocytic Leukemia
Riccardo Moia et al.
CANCERS (2020)
EMA Review of Daunorubicin and Cytarabine Encapsulated in Liposomes (Vyxeos, CPX-351) for the Treatment of Adults with Newly Diagnosed, Therapy-Related Acute Myeloid Leukemia or Acute Myeloid Leukemia with Myelodysplasia-Related Changes
Kyriaki Tzogani et al.
ONCOLOGIST (2020)
Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles
David C. Luther et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Polymeric vehicles for nucleic acid delivery
Alexandra S. Piotrowski-Daspit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites
Jun Cao et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Recent advances in siRNA delivery mediated by lipid-based nanoparticles
Sei Yonezawa et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
The regulation and function of CD20: an enigma of B-cell biology and targeted therapy
Gabriela Pavlasova et al.
HAEMATOLOGICA (2020)
Lipid-Based Drug Delivery Nanoplatforms for Colorectal Cancer Therapy
Chunhua Yang et al.
NANOMATERIALS (2020)
QbD aided development of ibrutinib-loaded nanostructured lipid carriers aimed for lymphatic targeting: evaluation using chylomicron flow blocking approach
Nagarjun Rangaraj et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Recent Advances of Gold Compounds in Anticancer Immunity
Shuang Yue et al.
FRONTIERS IN CHEMISTRY (2020)
Resurrection of Oral Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: A Historical Account From Bedside to Bench to Bedside
Cyrus R. Kumana et al.
FRONTIERS IN ONCOLOGY (2020)
Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
Edo Kon et al.
PHARMACEUTICS (2020)
Treatment of Chronic Lymphocytic Leukemia
Jan A. Burger
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Biodegradable diblock copolymeric PEG-PCL nanoparticles: Synthesis, characterization and applications as anticancer drug delivery agents
Akanksha Behl et al.
POLYMER (2020)
Cellular Interactions of Liposomes and PISA Nanoparticles during Human Blood Flow in a Microvascular Network
Mai N. Vu et al.
SMALL (2020)
The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells
Hussin A. Rothan et al.
VIROLOGY (2020)
Venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (CLL14): follow-up results from a multicentre, open-label, randomised, phase 3 trial
Othman Al-Sawaf et al.
LANCET ONCOLOGY (2020)
Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL
Ida Franiak-Pietryga et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia
Praveen Ramakrishnan Geethakumari et al.
EXPERT REVIEW OF HEMATOLOGY (2020)
Tailoring Iron Oxide Nanoparticles for Efficient Cellular Internalization and Endosomal Escape
Laura Rueda-Gensini et al.
NANOMATERIALS (2020)
A Review of Biodegradable Natural Polymer-Based Nanoparticles for Drug Delivery Applications
Humaira Idrees et al.
NANOMATERIALS (2020)
Effects of Two Kinds of Iron Nanoparticles as Reactive Oxygen Species Inducer and Scavenger on the Transcriptomic Profiles of Two Human Leukemia Cells with Different Stemness
Tao Luo et al.
NANOMATERIALS (2020)
Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
Shi Su et al.
PHARMACEUTICS (2020)
Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival
Nancy Nistico et al.
PHARMACEUTICALS (2020)
Inorganic nanoparticles in clinical trials and translations
Hui Huang et al.
NANO TODAY (2020)
Advances of Nanoparticles for Leukemia Treatment
Jie Shen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2020)
Immune Dysfunctions and Immune-Based Therapeutic Interventions in Chronic Lymphocytic Leukemia
Valentina Griggio et al.
FRONTIERS IN IMMUNOLOGY (2020)
Lenalidomide (LENA) Hybrid Gold Complex Nanoparticles: Synthesis, Physicochemical Evaluation, and Perspectives in Nanomedicine
Celia Arib et al.
ACS OMEGA (2020)
Maltotriose Conjugated Metal-Organic Frameworks for Selective Targeting and Photodynamic Therapy of Triple Negative Breast Cancer Cells and Tumor Associated Macrophages
Yoshie Sakamaki et al.
ADVANCED THERAPEUTICS (2020)
Nanomedicine - a promising therapy for hematological malignancies
Lifen Huang et al.
BIOMATERIALS SCIENCE (2020)
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia
Carmelo Gurnari et al.
CHEMOTHERAPY (2020)
Rituximab conjugated iron oxide nanoparticles for targeted imaging and enhanced treatment against CD20-positive lymphoma
Lina Song et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Biodegradable Microcapsules from D,L-PLA/PCL as Controlled Nifedipine Drug Delivery Carrier
Suci Hepy Astuti et al.
MACROMOLECULAR SYMPOSIA (2020)
BTK inhibitors and anti-CD20 monoclonal antibodies for treatment-naive elderly patients with CLL
Andrew Rogers et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2020)
Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery
Iti Chauhan et al.
ADVANCED PHARMACEUTICAL BULLETIN (2020)
Fludarabine-Specific Molecular Interactions with Maltose-Modified Poly(propyleneimine) Dendrimer Enable Effective Cell Entry of the Active Drug Form: Comparison with Clofarabine
Michal Gorzkiewicz et al.
BIOMACROMOLECULES (2019)
Chronic lymphocytic leukemia (CLL) treatment: So many choices, such great options
Sandhya Sharma et al.
CANCER (2019)
Potential Anticancer Activity of Auranofin
Takefumi Onodera et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2019)
Enhanced Oral Bioavailability of Ibrutinib Encapsulated Poly (Lactic-co-Glycolic Acid) Nanoparticles: Pharmacokinetic Evaluation in Rats
Abdullah S. Alshetaili et al.
CURRENT PHARMACEUTICAL ANALYSIS (2019)
Smart Nanoparticles for Drug Delivery Application: Development of Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine
Domenico Lombardo et al.
JOURNAL OF NANOMATERIALS (2019)
FDA-approved ferumoxytol displays anti-leukaemia efficacy against cells with low ferroportin levels
Vicenta Trujillo-Alonso et al.
NATURE NANOTECHNOLOGY (2019)
CPX-351: a nanoscale liposomal co-formulation of daunorubicin and cytarabine with unique biodistribution and tumor cell uptake properties
Lawrence D. Mayer et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Improving the Solubility, Dissolution, and Bioavailability of Ibrutinib by Preparing It in a Coamorphous State With Saccharin
Xiangjun Shi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment
Beatriz Garcia-Pinel et al.
NANOMATERIALS (2019)
Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment
Michael Hallek
AMERICAN JOURNAL OF HEMATOLOGY (2019)
ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model
Chi-Ling Chiang et al.
BLOOD (2019)
Chronic lymphocytic leukaemia: from genetics to treatment
Francesc Bosch et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
PEGylated liposomes: immunological responses
Marwa Mohamed et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)
Poly(D,L-Lactic Acid) Nanoparticle Size Reduction Increases Its Immunotoxicity
Jessica Da Silva et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
Cytotoxicity of Dendrimers
Anna Janaszewska et al.
BIOMOLECULES (2019)
Production of polycaprolactone nanoparticles with hydrodynamic diameters below 100 nm
Sandra Witt et al.
ENGINEERING IN LIFE SCIENCES (2019)
Iron and leukemia: new insights for future treatments
Fang Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
The evolving treatment landscape of chronic lymphocytic leukemia
Luana Schiattone et al.
CURRENT OPINION IN ONCOLOGY (2019)
Theranostic nanoparticles with tumor-specific enzyme-triggered size reduction and drug release to perform photothermal therapy for breast cancer treatment
Rui Liu et al.
ACTA PHARMACEUTICA SINICA B (2019)
Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications
Seyed Mohammadali Dadfar et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
A Perspective on Polylactic Acid-Based Polymers Use for Nanoparticles Synthesis and Applications
Tommaso Casalini et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss et al.
CLINICAL CANCER RESEARCH (2019)
Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics
Thomas Vangijzegem et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Polymeric siRNA gene delivery - transfection efficiency versus cytotoxicity
Anna Kargaard et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer-by-Layer Nanoparticles
Ki Young Choi et al.
ADVANCED FUNCTIONAL MATERIALS (2019)
Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery
Catriona McCallion et al.
BLOOD ADVANCES (2019)
Doxorubicin loaded ferritin nanoparticles for ferroptosis enhanced targeted killing of cancer cells
Runlin Yang et al.
RSC ADVANCES (2019)
From Biology to Therapy: The CLL Success Story
Deyan Y. Yosifov et al.
HEMASPHERE (2019)
Bendamustine-PAMAM Conjugates for Improved Apoptosis, Efficacy, and in Vivo Pharmacokinetics: A Sustainable Delivery Tactic
Avinash Gothwal et al.
MOLECULAR PHARMACEUTICS (2018)
Mesoporous Silica Nanoparticles for Drug Delivery: Current Insights
Maria Vallet-Regi et al.
MOLECULES (2018)
A Nanocarrier Skin-Targeted Drug Delivery System using an Ascorbic Acid Derivative
Yutaka Inoue et al.
PHARMACEUTICAL RESEARCH (2018)
Glycodendrimer Nanocarriers for Direct Delivery of Fludarabine Triphosphate to Leukemic Cells: Improved Pharmacokinetics and Pharmacodynamics of Fludarabine
Michal Gorzkiewicz et al.
BIOMACROMOLECULES (2018)
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project
Andy C. Rawstron et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2018)
Surface Functionalization and Targeting Strategies of Liposomes in Solid Tumor Therapy: A Review
Muhammad Kashif Riaz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Dexamethasone prodrugs as potent suppressors of the immunostimulatory effects of lipid nanoparticle formulations of nucleic acids
Sam Chen et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Evolution of CLL treatment - from chemoimmunotherapy to targeted and individualized therapy
Jan A. Burger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Recent biomedical applications of gold nanoparticles: A review
Narges Elahi et al.
TALANTA (2018)
Box-Behnken Design of Experiment Assisted Development and Optimization of Bendamustine HCl loaded Hydroxyapatite Nanoparticles
Shindu C. Thomas et al.
CURRENT DRUG DELIVERY (2018)
Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective
Walaa Darwiche et al.
FRONTIERS IN IMMUNOLOGY (2018)
Novel Self-Assembled Ibrutinib-Phospholipid Complex for Potently Peroral Delivery of Poorly Soluble Drugs with pH-Dependent Solubility
Qiujun Qiu et al.
AAPS PHARMSCITECH (2018)
Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic
Samer Bayda et al.
CURRENT MEDICINAL CHEMISTRY (2018)
PEGylation and anti-PEG antibodies
Amr S. Abu Lila et al.
ENGINEERING OF BIOMATERIALS FOR DRUG DELIVERY SYSTEMS: BEYOND POLYETHYLENE GLYCOL (2018)
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Fereydoon Abedi-Gaballu et al.
APPLIED MATERIALS TODAY (2018)
PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells
Ida Franiak-Pietryga et al.
MACROMOLECULAR BIOSCIENCE (2017)
Lenalidomide in the treatment of chronic lymphocytic leukemia
Gilad Itchaki et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Determination and quantification of intracellular fludarabine triphosphate, cladribine triphosphate and clofarabine triphosphate by LC-MS/MS in human cancer cells
Jean-Yves Puy et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Intracellular pH-responsive and rituximabconjugated mesoporous silica nanoparticles for targeted drug delivery to lymphoma B cells
Shoubing Zhou et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study
Ida Franiak-Pietryga et al.
MACROMOLECULAR BIOSCIENCE (2017)
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model
L. D'Abundo et al.
ONCOGENE (2017)
Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia
Kaylin M. McMahon et al.
ONCOTARGET (2017)
Au nanoclusters suppress chronic lymphocytic leukaemia cells by inhibiting thioredoxin reductase 1 to induce intracellular oxidative stress and apoptosis
Qiong Li et al.
SCIENCE BULLETIN (2017)
Nanoparticles-Emerging Potential for Managing Leukemia and Lymphoma
Raquel Vinhas et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2017)
Immunoliposomes: A review on functionalization strategies and targets for drug delivery
Josimar O. Eloy et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Polymeric Vectors for Strategic Delivery of Nucleic Acids
Andrew Dunn et al.
NANO LIFE (2017)
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles
Sara Capolla et al.
NANO RESEARCH (2016)
Polylactic acid (PLA) controlled delivery carriers for biomedical applications
Betty Tyler et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review
Shady Farah et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway
Ida Franiak-Pietryga et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2016)
Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance
Aleksandra Szulc et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
Using Gold Nanoparticles as Delivery Vehicles for Targeted Delivery of Chemotherapy Drug Fludarabine Phosphate to Treat Hematological Cancers
Steven Song et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2016)
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
Barbara Eichhorst et al.
LANCET ONCOLOGY (2016)
CD44 Mediated Nonviral Gene Delivery into Human Embryonic Stem Cells via Hyaluronic-Acid-Coated Nanoparticles
Jonathan Yen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2016)
CD44 Mediated Nonviral Gene Delivery into Human Embryonic Stem Cells via Hyaluronic-Acid-Coated Nanoparticles
Jonathan Yen et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2016)
The molecular pathogenesis of chronic lymphocytic leukaemia
Giulia Fabbri et al.
NATURE REVIEWS CANCER (2016)
Idelalisib: A Novel PI3K Inhibitor for Chronic Lymphocytic Leukemia
Arpita Shah et al.
ANNALS OF PHARMACOTHERAPY (2015)
FDA Approval: Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma and Previously Treated Chronic Lymphocytic Leukemia
R. Angelo de Claro et al.
CLINICAL CANCER RESEARCH (2015)
Applications of nanoparticles in treatment and diagnosis of leukemia
Govind Soni et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2015)
Synergistic effects in mechanical properties of PLA/PCL blends with optimized composition, processing, and morphology
Aleksandra Ostafinska et al.
RSC ADVANCES (2015)
A Comprehensive Review on Cyclodextrin-Based Carriers for Delivery of Chemotherapeutic Cytotoxic Anticancer Drugs
Bina Gidwani et al.
BIOMED RESEARCH INTERNATIONAL (2015)
The role of CD44 in the pathophysiology of chronic lymphocytic leukemia
Julia Christine Gutjahr et al.
FRONTIERS IN IMMUNOLOGY (2015)
Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin
Kehinde U. A. Adekola et al.
LEUKEMIA & LYMPHOMA (2015)
Auranofin Induces Lethal Oxidative and Endoplasmic Reticulum Stress and Exerts Potent Preclinical Activity against Chronic Lymphocytic Leukemia
Warren Fiskus et al.
CANCER RESEARCH (2014)
Dual stimuli-responsive nano-vehicles for controlled drug delivery: mesoporous silica nanoparticles end-capped with natural chitosan
Abdul Hakeem et al.
CHEMICAL COMMUNICATIONS (2014)
Chronic Lymphocytic Leukemia A Clinical Review
Chadi Nabhan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Dendrimer as nanocarrier for drug delivery
Prashant Kesharwani et al.
PROGRESS IN POLYMER SCIENCE (2014)
A review of a novel, Bruton’s tyrosine kinase inhibitor, ibrutinib
Chung-Shien Lee et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2014)
Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release
Zeting Yuan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches
Rachel E. Hayden et al.
LEUKEMIA & LYMPHOMA (2012)
Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery
Azza A. Mahmoud et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Bendamustine for the Treatment of Chronic Lymphocytic Leukemia and Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma
Trevor W. Dennie et al.
CLINICAL THERAPEUTICS (2009)
Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells
Che K. Lim et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2008)
FDA drug approval summary: Alemtuzumab as single-agent treatment for B-Cell chronic lymphocytic leukemia
Suzanne Demko et al.
ONCOLOGIST (2008)
Nucleoside analogues: mechanisms of drug resistance and reversal strategies
CM Galmarini et al.
LEUKEMIA (2001)
Share Paper
